N-((S)-1-(((S)-1-Hydroxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide
N-((S)-1-(((S)-1-Hydroxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide 物理性質
- 沸点 :
- 672.0±55.0 °C(Predicted)
- 比重(密度) :
- 1.199±0.06 g/cm3(Predicted)
- 貯蔵温度 :
- 2-8°C
- 溶解性:
- Chloroform (Slightly), Methanol (Slightly)
- 酸解離定数(Pka):
- 11.90±0.46(Predicted)
- 外見 :
- Solid
- 色:
- White to Off-White
安全性情報
N-((S)-1-(((S)-1-Hydroxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide 価格
もっと(2)
メーカー |
製品番号 |
製品説明 |
CAS番号 |
包装 |
価格 |
更新時間 |
購入 |
富士フイルム和光純薬株式会社(wako)
|
W01TRCH935905 |
(S)-Hydroxy Des(boric Acid) Bortezomib |
289472-81-7 |
0.5mg |
¥73500 |
2024-03-01 |
購入 |
富士フイルム和光純薬株式会社(wako)
|
W01TRCH935905 |
(S)-Hydroxy Des(boric Acid) Bortezomib |
289472-81-7 |
5mg |
¥558000 |
2024-03-01 |
購入 |
N-((S)-1-(((S)-1-Hydroxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide 化学特性,用途語,生産方法
使用
(S)-Hydroxy Des(boric Acid) Bortezomib is an impurity in the synthesis of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway.
N-((S)-1-(((S)-1-Hydroxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide 上流と下流の製品情報
原材料
準備製品
N-((S)-1-(((S)-1-Hydroxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide 生産企業
Global( 69)Suppliers
289472-81-7()キーワード:
- 289472-81-7
- 2-PyrazinecarboxaMide, N-[(1S)-2-[[(1S)-1-hydroxy-3-Methylbutyl]aMino]-2-oxo-1-(phenylMethyl)ethyl]-
- (S)-Hydroxy Des(boric Acid) BortezoMib
- (N-[(1S)-1-hydroxy-3-Methylbutyl]-Nα-(pyrazin-2-ylcarbonyl)-L-phenylalaninaMide
- Bortezomib Impurity 48
- Bortezomib Impurity J
- N-[(2S)-1-[[(1S)-1-hydroxy-3-methylbutyl]amino]-1-oxo-3-phenylpropan-2-yl]pyrazine-2-carboxamide
- Bortezomib USP IMP J
- Bortezomib Impurity D
- Bortezomib USP Related Compoud J
- N-[(1S)-2-[[(1S)-1-hydroxy-3-methylbutyl]amino]-2-oxo-1-(phenylmethyl)ethyl]-2-Pyrazinecarboxamide
- N-[(1S)-2-[[(1S)-1-hydroxy-3-methylbutyl]amino]-2-oxo-1-(phenylmethyl)ethyl]-pyrazi
- Bortezomib USP Impurity J
- Bortezomib Related Compund J/ (S,S)-Bortezomib Hydroxyisopentyl Amide Analog (Bortezomib Hydroxy S,S-Isomer Impurity)
- BortezomibHydroxy(1S,2S)-Isomer
- (S,S)-Bortezomib Hydroxyisopentyl Amide Analog
- Bortezomib EP IMP M
- N-[(2S)-1-[[(1S)-1-hydroxy-3-methylbutyl]amino]-1-oxo-3-phenylprop
- N-((S)-1-(((S)-1-Hydroxy-3-Methylbutyl)aMino)-1-oxo-3-phenyl